Depressive disorders in the elderly and dementia: An update.

Alzheimer’s disease dementia depression differential diagnosis therapeutics

Journal

Dementia & neuropsychologia
ISSN: 1980-5764
Titre abrégé: Dement Neuropsychol
Pays: Brazil
ID NLM: 101506587

Informations de publication

Date de publication:
Historique:
entrez: 25 3 2020
pubmed: 25 3 2020
medline: 25 3 2020
Statut: ppublish

Résumé

The relationship between depressive disorders in the elderly and dementia, particularly Alzheimer's disease (AD), is highly complex. While the nature of this relationship is still a matter of debate, differential diagnosis and treatment remain a great clinical challenge. We review recent findings on the conundrum of depressive disorders in the elderly and AD. There is a biological continuum between depressive disorders in the elderly - or at least a subgroup of them - and AD. While elderly subjects with depression and patients with AD exhibit higher circulating levels of pro-inflammatory molecules and lower BDNF than matched controls, CSF levels of Aβ42 can discriminate AD from depressive disorders in the elderly. The role of antidepressant treatment as a strategy to minimize the risk of AD remains to be established. A relação entre transtornos depressivos em idosos e demência, particularmente a doença de Alzheimer (DA), é altamente complexa. Embora a natureza desse relacionamento ainda seja motivo de debate, o diagnóstico e o tratamento diferenciais continuam sendo um grande desafio clínico. Revisamos descobertas recentes sobre o dilema de transtornos depressivos em idosos e DA. Existe um contínuo biológico entre os transtornos depressivos em idosos – ou pelo menos um subgrupo deles – e a DA. Enquanto indivíduos idosos com depressão e pacientes com DA exibem níveis circulantes mais altos de moléculas pró-inflamatórias e menor BDNF do que os controles correspondentes, os níveis de Aβ42 no LCR podem discriminar a DA de distúrbios depressivos em idosos. O papel do tratamento antidepressivo como estratégia para minimizar o risco de DA ainda precisa ser estabelecido.

Autres résumés

Type: Publisher (por)
A relação entre transtornos depressivos em idosos e demência, particularmente a doença de Alzheimer (DA), é altamente complexa. Embora a natureza desse relacionamento ainda seja motivo de debate, o diagnóstico e o tratamento diferenciais continuam sendo um grande desafio clínico. Revisamos descobertas recentes sobre o dilema de transtornos depressivos em idosos e DA. Existe um contínuo biológico entre os transtornos depressivos em idosos – ou pelo menos um subgrupo deles – e a DA. Enquanto indivíduos idosos com depressão e pacientes com DA exibem níveis circulantes mais altos de moléculas pró-inflamatórias e menor BDNF do que os controles correspondentes, os níveis de Aβ42 no LCR podem discriminar a DA de distúrbios depressivos em idosos. O papel do tratamento antidepressivo como estratégia para minimizar o risco de DA ainda precisa ser estabelecido.

Identifiants

pubmed: 32206191
doi: 10.1590/1980-57642020dn14-010001
pmc: PMC7077867
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-6

Déclaration de conflit d'intérêts

Disclosure: The authors report no conflicts of interest.

Références

Curr Alzheimer Res. 2014 Jan;11(1):27-39
pubmed: 24251394
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):619-24
pubmed: 17717021
J Psychiatr Res. 2015 Oct;69:35-41
pubmed: 26343592
Braz J Psychiatry. 2013 Apr-Jun;35(2):142-9
pubmed: 23904019
Neurosci Lett. 2007 Apr 6;416(1):39-42
pubmed: 17331644
J Affect Disord. 2018 Dec 1;241:176-181
pubmed: 30125821
Psychol Med. 2008 Feb;38(2):163-75
pubmed: 17588275
Psychoneuroendocrinology. 2014 Mar;41:46-62
pubmed: 24495607
Arch Gen Psychiatry. 2006 May;63(5):530-8
pubmed: 16651510
Neurol Neurochir Pol. 2017 Jan - Feb;51(1):24-32
pubmed: 28341039
Psychol Med. 2014 Jul;44(10):2029-40
pubmed: 24168753
BMC Med. 2016 Nov 3;14(1):161
pubmed: 27806704
Brain Behav Immun. 2012 Oct;26(7):1180-8
pubmed: 22687336
Biol Psychiatry. 2010 Jun 15;67(12):1191-8
pubmed: 20299006
Am J Geriatr Psychiatry. 2018 Oct;26(10):1050-1060
pubmed: 30037778
Int J Mol Sci. 2018 Jan 12;19(1):
pubmed: 29329256
CNS Drugs. 2019 Jan;33(1):17-29
pubmed: 30456746
Brain Behav Immun. 2015 Oct;49:206-15
pubmed: 26065825
J Neural Transm (Vienna). 2011 Apr;118(4):579-85
pubmed: 21210286
Br J Psychiatry. 2013 May;202(5):329-35
pubmed: 23637108
Int J Mol Sci. 2016 Dec 02;17(12):
pubmed: 27918465
Am J Geriatr Psychiatry. 2018 Jan;26(1):100-106
pubmed: 28755989
J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):876-882
pubmed: 28794151
Neuropsychiatr Dis Treat. 2016 Aug 24;12:2105-14
pubmed: 27601905
World J Biol Psychiatry. 2010 Apr;11(3):550-5
pubmed: 20109109
BMC Med. 2017 Apr 19;15(1):81
pubmed: 28424070
J Alzheimers Dis. 2016 Sep 6;54(2):615-33
pubmed: 27497481
Psychol Med. 2007 Dec;37(12):1693-702
pubmed: 17610767
Alzheimers Dement. 2017 Jan;13(1):59-71
pubmed: 27693188
Lancet Psychiatry. 2018 Jul;5(7):581-590
pubmed: 29887519
Curr Alzheimer Res. 2016;13(10):1066-82
pubmed: 27137220
J Affect Disord. 2011 Nov;134(1-3):20-31
pubmed: 21163534
Am J Geriatr Psychiatry. 2013 May;21(5):433-49
pubmed: 23570887
Neural Regen Res. 2017 Apr;12(4):549-557
pubmed: 28553325
Acta Neurol Scand. 2006 Apr;113(4):211-20
pubmed: 16542159
Int Psychogeriatr. 2018 Feb;30(2):185-196
pubmed: 28899446
J Neural Transm (Vienna). 2009 Feb;116(2):203-12
pubmed: 19142572
Aging Ment Health. 2013;17(1):1-11
pubmed: 22934752
J Affect Disord. 2001 Jun;65(1):19-26
pubmed: 11426505
Br J Psychiatry. 1996 Jun;168(6):679-87
pubmed: 8773809
Postgrad Med. 2001 Oct;Spec No Pharmacotherapy:1-86
pubmed: 17205639
Psychosom Med. 2011 Feb-Mar;73(2):114-26
pubmed: 21257974
Psychiatry Res. 2019 Jan;271:343-350
pubmed: 30529317
J Neural Transm (Vienna). 2016 Dec;123(12):1443-1447
pubmed: 27531278
Acta Psychiatr Scand. 2018 Jun;137(6):491-502
pubmed: 29457245
Mol Chem Neuropathol. 1995 Dec;26(3):231-45
pubmed: 8748926
Cochrane Database Syst Rev. 2018 Aug 31;8:CD003944
pubmed: 30168578
Neurology. 2012 Jan 3;78(1):47-54
pubmed: 22170879
J Alzheimers Dis. 2010;21(4):1119-28
pubmed: 21504133
Lancet Psychiatry. 2016 Jul;3(7):628-35
pubmed: 27138970
Am J Geriatr Psychiatry. 2017 Oct;25(10):1123-1134
pubmed: 28479153
Arch Gen Psychiatry. 2011 Jan;68(1):51-60
pubmed: 21199965
J Affect Disord. 2016 Mar 1;192:226-33
pubmed: 26748738
Int J Geriatr Psychiatry. 2016 Aug;31(8):905-11
pubmed: 26680599
World J Biol Psychiatry. 2001 Apr;2(2):83-8
pubmed: 12587189
JAMA Psychiatry. 2017 Jul 1;74(7):712-718
pubmed: 28514478
J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69(6):845-51
pubmed: 25149921
Psychoneuroendocrinology. 2019 Jan;99:20-27
pubmed: 30172071
BMC Geriatr. 2018 Jun 25;18(1):149
pubmed: 29940870
Int J Neuropsychopharmacol. 2015 Jul 25;19(2):
pubmed: 26209859
CNS Neurosci Ther. 2012 Jul;18(7):524-9
pubmed: 22530600
Prog Neurobiol. 2012 Jul;98(1):99-143
pubmed: 22609700
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jul 4;68:1-8
pubmed: 26903140
Cell Tissue Res. 2018 Sep;373(3):729-741
pubmed: 29450725

Auteurs

Natália S Dias (NS)

Neuroscience Program, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Izabela G Barbosa (IG)

Neuroscience Program, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Department of Mental Health, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Weihong Kuang (W)

Department of Psychiatry, West China Hospital of Sichuan University, Chengdu, China.

Antonio L Teixeira (AL)

Neuroscience Program, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Department of Psychiatry and Behavioral Sciences, UT Health, Houston, United States.
Instituto de Ensino e Pesquisa, Santa Casa BH, Belo Horizonte, MG, Brazil.

Classifications MeSH